US Stock MarketDetailed Quotes

HBIO Harvard Bioscience

Watchlist
  • 3.370
  • 0.0000.00%
Close May 17 16:00 ET
  • 3.370
  • 0.0000.00%
Pre 09:05 ET
146.36MMarket Cap-16850P/E (TTM)

Harvard Bioscience Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.57%1.4M
1,117.71%14.03M
60.62%4.3M
571.96%4.36M
1,969.47%3.55M
191.24%1.81M
-8.72%1.15M
2,189.74%2.68M
198.33%649K
-124.74%-190K
Net income from continuing operations
-854.66%-4.69M
64.11%-3.42M
-9.12%-1.82M
63.61%-1.24M
-140.25%-980K
109.04%622K
-3,204.17%-9.52M
-273.36%-1.67M
-1,902.94%-3.41M
693.90%2.44M
Operating gains losses
425.56%1.31M
---403K
--0
--0
--0
---403K
----
----
--0
----
Depreciation and amortization
3.49%1.78M
-7.62%7M
-9.38%1.78M
-8.11%1.78M
-5.96%1.72M
-6.87%1.72M
-0.60%7.58M
2.03%1.96M
3.03%1.94M
-4.24%1.83M
Deferred tax
423.64%178K
181.16%336K
196.06%244K
100.50%6K
-87.88%141K
55.28%-55K
-25.45%-414K
-251.19%-254K
-515.38%-1.2M
565.20%1.16M
Other non cash items
0.00%70K
107.73%280K
101.83%70K
0.00%70K
0.00%70K
0.00%70K
-1,392.86%-3.62M
-5,571.43%-3.83M
0.00%70K
0.00%70K
Change In working capital
231.79%1.71M
69.37%4.6M
53.34%2.39M
70.22%3.59M
97.26%-83K
-162.43%-1.3M
126.65%2.72M
138.59%1.56M
164.93%2.11M
-76.30%-3.03M
-Change in receivables
176.27%704K
-83.05%810K
26.48%-941K
-26.45%1.82M
-58.91%855K
-161.29%-923K
211.32%4.78M
64.12%-1.28M
335.52%2.47M
897.32%2.08M
-Change in inventory
-111.30%-617K
504.76%1.52M
132.53%1.35M
-109.62%-225K
150.77%690K
77.68%-292K
104.30%252K
132.05%581K
253.61%2.34M
29.37%-1.36M
-Change in payables and accrued expense
1,746.00%2.47M
139.67%555K
-114.29%-140K
149.64%965K
96.21%-120K
-105.50%-150K
-157.01%-1.4M
77.22%980K
-814.71%-1.94M
-268.84%-3.16M
-Change in other current assets
3.25%-298K
248.31%1.65M
32.37%1.7M
317.11%1.22M
-544.44%-960K
33.91%-308K
207.97%474K
-22.07%1.29M
1.75%-561K
115.18%216K
-Change in other current liabilities
-18.13%-430K
-117.78%-1.08M
-125.22%-85K
-46.69%-377K
48.57%-252K
-328.24%-364K
80.63%-495K
122.38%337K
23.28%-257K
-2,622.22%-490K
-Change in other working capital
-116.19%-120K
227.01%1.14M
245.80%503K
216.67%190K
4.82%-296K
347.00%741K
-277.43%-896K
-153.32%-345K
242.86%60K
-988.57%-311K
Cash from discontinued investing activities
Operating cash flow
-22.57%1.4M
1,117.71%14.03M
60.62%4.3M
571.96%4.36M
1,969.47%3.55M
191.24%1.81M
-8.72%1.15M
2,189.74%2.68M
198.33%649K
-124.74%-190K
Investing cash flow
Cash flow from continuing investing activities
-178.13%-225K
-13.14%-1.8M
-351.49%-1.06M
9.28%-401K
-41.40%-625K
161.15%288K
-18.22%-1.59M
34.36%-235K
7.92%-442K
-114.56%-442K
Capital expenditure reported
---75K
---523K
----
----
----
--0
--0
----
----
----
Net PPE purchase and sale
-187.95%-645K
-12.45%-1.79M
-253.19%-830K
50.90%-217K
-16.97%-517K
52.44%-224K
-33.05%-1.59M
34.36%-235K
7.92%-442K
-114.56%-442K
Net intangibles purchase and sale
----
----
----
---184K
----
----
----
----
--0
----
Net business purchase and sale
--0
--512K
--0
--0
--0
--512K
--0
--0
--0
--0
Net investment purchase and sale
--495K
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-178.13%-225K
-13.14%-1.8M
-351.49%-1.06M
9.28%-401K
-41.40%-625K
161.15%288K
-18.22%-1.59M
34.36%-235K
7.92%-442K
-114.56%-442K
Financing cash flow
Cash flow from continuing financing activities
63.53%-1.06M
-327.71%-12.13M
-50.77%-4.12M
-829.44%-2.75M
-310.90%-2.38M
-3,177.66%-2.89M
-1,025.79%-2.84M
-205.24%-2.73M
-22.59%377K
-201.04%-578K
Net issuance payments of debt
63.99%-1.02M
-490.20%-10.54M
10.00%-2.25M
-492.86%-2.75M
-390.91%-2.7M
-603.72%-2.84M
-3,672.00%-1.79M
-181.97%-2.5M
-65.00%700K
-10.00%-550K
Proceeds from stock option exercised by employees
-85.58%15K
61.18%930K
-10.82%206K
--0
147.01%620K
235.48%104K
-82.59%577K
-42.96%231K
-57.33%64K
-69.94%251K
Net other financing activities
69.87%-47K
-54.98%-2.52M
-349.46%-2.07M
--0
-5.73%-295K
68.86%-156K
54.98%-1.63M
46.46%-461K
76.73%-387K
47.06%-279K
Cash from discontinued financing activities
Financing cash flow
63.53%-1.06M
-327.71%-12.13M
-50.77%-4.12M
-829.44%-2.75M
-310.90%-2.38M
-3,177.66%-2.89M
-1,025.79%-2.84M
-205.24%-2.73M
-22.59%377K
-201.04%-578K
Net cash flow
Beginning cash position
-4.99%4.28M
-42.36%4.51M
3.81%5.34M
1.53%4.32M
-30.26%3.79M
-42.36%4.51M
-5.96%7.82M
-7.28%5.14M
-31.71%4.26M
-6.57%5.43M
Current changes in cash
115.51%123K
102.90%95K
-205.59%-874K
107.19%1.21M
145.62%552K
66.44%-793K
-877.61%-3.28M
-112.15%-286K
189.43%584K
-427.03%-1.21M
Effect of exchange rate changes
-304.05%-151K
-742.11%-320K
47.71%-183K
-164.45%-194K
-147.22%-17K
396.00%74K
76.40%-38K
-337.50%-350K
936.11%301K
-30.77%36K
End cash Position
12.30%4.26M
-4.99%4.28M
-4.99%4.28M
3.81%5.34M
1.53%4.32M
-30.26%3.79M
-42.36%4.51M
-42.36%4.51M
-7.28%5.14M
-31.71%4.26M
Free cash flow
-56.99%683K
2,775.11%11.72M
32.65%3.24M
1,813.04%3.96M
563.13%2.93M
164.63%1.59M
-427.71%-438K
1,114.11%2.44M
118.16%207K
-212.46%-632K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.57%1.4M1,117.71%14.03M60.62%4.3M571.96%4.36M1,969.47%3.55M191.24%1.81M-8.72%1.15M2,189.74%2.68M198.33%649K-124.74%-190K
Net income from continuing operations -854.66%-4.69M64.11%-3.42M-9.12%-1.82M63.61%-1.24M-140.25%-980K109.04%622K-3,204.17%-9.52M-273.36%-1.67M-1,902.94%-3.41M693.90%2.44M
Operating gains losses 425.56%1.31M---403K--0--0--0---403K----------0----
Depreciation and amortization 3.49%1.78M-7.62%7M-9.38%1.78M-8.11%1.78M-5.96%1.72M-6.87%1.72M-0.60%7.58M2.03%1.96M3.03%1.94M-4.24%1.83M
Deferred tax 423.64%178K181.16%336K196.06%244K100.50%6K-87.88%141K55.28%-55K-25.45%-414K-251.19%-254K-515.38%-1.2M565.20%1.16M
Other non cash items 0.00%70K107.73%280K101.83%70K0.00%70K0.00%70K0.00%70K-1,392.86%-3.62M-5,571.43%-3.83M0.00%70K0.00%70K
Change In working capital 231.79%1.71M69.37%4.6M53.34%2.39M70.22%3.59M97.26%-83K-162.43%-1.3M126.65%2.72M138.59%1.56M164.93%2.11M-76.30%-3.03M
-Change in receivables 176.27%704K-83.05%810K26.48%-941K-26.45%1.82M-58.91%855K-161.29%-923K211.32%4.78M64.12%-1.28M335.52%2.47M897.32%2.08M
-Change in inventory -111.30%-617K504.76%1.52M132.53%1.35M-109.62%-225K150.77%690K77.68%-292K104.30%252K132.05%581K253.61%2.34M29.37%-1.36M
-Change in payables and accrued expense 1,746.00%2.47M139.67%555K-114.29%-140K149.64%965K96.21%-120K-105.50%-150K-157.01%-1.4M77.22%980K-814.71%-1.94M-268.84%-3.16M
-Change in other current assets 3.25%-298K248.31%1.65M32.37%1.7M317.11%1.22M-544.44%-960K33.91%-308K207.97%474K-22.07%1.29M1.75%-561K115.18%216K
-Change in other current liabilities -18.13%-430K-117.78%-1.08M-125.22%-85K-46.69%-377K48.57%-252K-328.24%-364K80.63%-495K122.38%337K23.28%-257K-2,622.22%-490K
-Change in other working capital -116.19%-120K227.01%1.14M245.80%503K216.67%190K4.82%-296K347.00%741K-277.43%-896K-153.32%-345K242.86%60K-988.57%-311K
Cash from discontinued investing activities
Operating cash flow -22.57%1.4M1,117.71%14.03M60.62%4.3M571.96%4.36M1,969.47%3.55M191.24%1.81M-8.72%1.15M2,189.74%2.68M198.33%649K-124.74%-190K
Investing cash flow
Cash flow from continuing investing activities -178.13%-225K-13.14%-1.8M-351.49%-1.06M9.28%-401K-41.40%-625K161.15%288K-18.22%-1.59M34.36%-235K7.92%-442K-114.56%-442K
Capital expenditure reported ---75K---523K--------------0--0------------
Net PPE purchase and sale -187.95%-645K-12.45%-1.79M-253.19%-830K50.90%-217K-16.97%-517K52.44%-224K-33.05%-1.59M34.36%-235K7.92%-442K-114.56%-442K
Net intangibles purchase and sale ---------------184K------------------0----
Net business purchase and sale --0--512K--0--0--0--512K--0--0--0--0
Net investment purchase and sale --495K------------------0----------------
Cash from discontinued investing activities
Investing cash flow -178.13%-225K-13.14%-1.8M-351.49%-1.06M9.28%-401K-41.40%-625K161.15%288K-18.22%-1.59M34.36%-235K7.92%-442K-114.56%-442K
Financing cash flow
Cash flow from continuing financing activities 63.53%-1.06M-327.71%-12.13M-50.77%-4.12M-829.44%-2.75M-310.90%-2.38M-3,177.66%-2.89M-1,025.79%-2.84M-205.24%-2.73M-22.59%377K-201.04%-578K
Net issuance payments of debt 63.99%-1.02M-490.20%-10.54M10.00%-2.25M-492.86%-2.75M-390.91%-2.7M-603.72%-2.84M-3,672.00%-1.79M-181.97%-2.5M-65.00%700K-10.00%-550K
Proceeds from stock option exercised by employees -85.58%15K61.18%930K-10.82%206K--0147.01%620K235.48%104K-82.59%577K-42.96%231K-57.33%64K-69.94%251K
Net other financing activities 69.87%-47K-54.98%-2.52M-349.46%-2.07M--0-5.73%-295K68.86%-156K54.98%-1.63M46.46%-461K76.73%-387K47.06%-279K
Cash from discontinued financing activities
Financing cash flow 63.53%-1.06M-327.71%-12.13M-50.77%-4.12M-829.44%-2.75M-310.90%-2.38M-3,177.66%-2.89M-1,025.79%-2.84M-205.24%-2.73M-22.59%377K-201.04%-578K
Net cash flow
Beginning cash position -4.99%4.28M-42.36%4.51M3.81%5.34M1.53%4.32M-30.26%3.79M-42.36%4.51M-5.96%7.82M-7.28%5.14M-31.71%4.26M-6.57%5.43M
Current changes in cash 115.51%123K102.90%95K-205.59%-874K107.19%1.21M145.62%552K66.44%-793K-877.61%-3.28M-112.15%-286K189.43%584K-427.03%-1.21M
Effect of exchange rate changes -304.05%-151K-742.11%-320K47.71%-183K-164.45%-194K-147.22%-17K396.00%74K76.40%-38K-337.50%-350K936.11%301K-30.77%36K
End cash Position 12.30%4.26M-4.99%4.28M-4.99%4.28M3.81%5.34M1.53%4.32M-30.26%3.79M-42.36%4.51M-42.36%4.51M-7.28%5.14M-31.71%4.26M
Free cash flow -56.99%683K2,775.11%11.72M32.65%3.24M1,813.04%3.96M563.13%2.93M164.63%1.59M-427.71%-438K1,114.11%2.44M118.16%207K-212.46%-632K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg